Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Forte Biosciences Logo
Forte Biosciences Growth Score
79
CB Rank
60246
Heat Score
59
Forte Biosciences is a biotechnology company that focuses on dermatology.
Founded
obfuscation
PublicPost-IPO Equity Sherman Oaks, California, United States11-50 www.fortebiorx.com/home/default.aspx
Biotechnology
Health Care
Life Science
Pharmaceutical
Overview

Forte Biosciences
Total Funding
obfuscation
Growth Score
79
Heat Score
59

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score79
-12 pts
in past quarter
Heat Score 59
16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Forte Biosciences

CB Rank
60246
Forte Biosciences is a biotechnology company that focuses on dermatology.
Founded
obfuscation
PublicPost-IPO Equity Sherman Oaks, California, United States11-50 www.fortebiorx.com/home/default.aspx
Biotechnology
Health Care
Life Science
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Forte Biosciences, Inc.
Operating Status Active
Stock Symbol  NASDAQ:FBRX
Company Type For Profit
Founders  Paul Wagner
About the Company
Forte Biosciences is a biotechnology company that focuses on dermatology. The company's lead product, FB-401, is a topically applied live biotherapeutic developed in collaboration with the National Institutes of Health and the National Institute of Allergy and Infectious Diseases for the treatment of inflammatory skin disease.
Phone Number +1 (858) 625-1025
Contact Email inquiry@fortebiorx.com
Predictions & Insights

Growth Insight

See this Growth Insight
Forte Biosciences is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

FB102
FB102 is a molecule designed to act as a CD122 antagonist targeting autoimmune and autoimmune-related diseases by modulating immune cell activity.

Research & Development

Forte Biosciences is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Ikarian Capital Logo
Ikarian Capital
—
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
Ikarian Capital Logo
Ikarian Capital
—
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
Ikarian Capital Logo
Ikarian Capital
—
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
Ikarian Capital Logo
Ikarian Capital
—
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—
Ikarian Capital Logo
Ikarian Capital
—
Post-IPO Equity - Forte Biosciences Logo
Post-IPO Equity - Forte Biosciences
—

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 4 Board Members and Advisors 1 Contacts 5

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,012
-25.48%
 in past month

IT Spend

$50.5KThis year, Forte Biosciences is projected to spend $50.5K on IT, according to Aberdeen.

Active Website Tech Count

4Forte Biosciences is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 5m, Google Analytics 4, and  GStatic Google Static Content.
Sub-Organizations
Frequently Asked Questions

Where is Forte Biosciences's headquarters? Forte Biosciences is located in Sherman Oaks, California, United States.Who invested in Forte Biosciences? Forte Biosciences has 9 investors including Ikarian Capital and  OrbiMed.When was the last funding round for Forte Biosciences? Forte Biosciences closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Forte Biosciences's competitors? Alternatives and possible competitors to Forte Biosciences may include Apogee Therapeutics, Alumis, and  Roivant Sciences.How much funding has Forte Biosciences raised to date? Forte Biosciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|